Familial pulmonary arterial hypertension by KDR heterozygous loss of function
暂无分享,去创建一个
M. Humbert | S. Gräf | N. Morrell | L. Faivre | B. Girerd | F. Perros | N. Favrolt | D. Montani | M. Eyries | F. Soubrier | M. Riou | G. Manaud
[1] Yufeng Shen,et al. Reduced transfer coefficient of carbon monoxide in pulmonary arterial hypertension implicates rare protein-truncating variants in KDR , 2019 .
[2] W. Seeger,et al. Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension. , 2019, American journal of respiratory and critical care medicine.
[3] W. Chung,et al. Genetics and genomics of pulmonary arterial hypertension , 2019, European Respiratory Journal.
[4] M. Humbert,et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives , 2019, European Respiratory Journal.
[5] Paul G. Williams,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.
[6] Y. Mao,et al. Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension , 2019, European Respiratory Journal.
[7] M. Humbert,et al. Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases , 2019, European Respiratory Journal.
[8] Sunday S. Oladipupo,et al. Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1) , 2018, Scientific Reports.
[9] Henning Gall,et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension , 2018, Nature Communications.
[10] M. Eyries,et al. Genetic analyses in a cohort of children with pulmonary hypertension , 2016, European Respiratory Journal.
[11] N. Westerhof,et al. Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[12] D. Penny,et al. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report , 2016, BMC Pulmonary Medicine.
[13] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[14] M. Humbert,et al. Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects , 2015, Human mutation.
[15] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[16] A. Alzoubi,et al. Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats. , 2014, American journal of physiology. Heart and circulatory physiology.
[17] W. Chung,et al. A novel channelopathy in pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[18] E. Bongers,et al. TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension , 2013, Journal of Medical Genetics.
[19] W. Chung,et al. Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension , 2012, Circulation. Cardiovascular genetics.
[20] Jing Zheng,et al. Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor. , 2010, Endocrinology.
[21] L. Farkas,et al. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. , 2009, The Journal of clinical investigation.
[22] Manuel Corpas,et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.
[23] S. Surrey,et al. Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis , 2008, Journal of cellular and molecular medicine.
[24] G. Perkins,et al. Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells , 2007, Critical care medicine.
[25] N. Voelkel,et al. Vascular endothelial growth factor in the lung. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[26] Napoleone Ferrara,et al. Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.
[27] G. Semenza,et al. Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.
[28] M. Shibuya,et al. A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells , 2001, The EMBO journal.
[29] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] M. Humbert,et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.
[31] P. Hirth,et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.
[32] H. Farber,et al. VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.
[33] N. Voelkel,et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[34] J. Shannon,et al. Tissue interactions mediate early events in pulmonary vasculogenesis , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.
[35] A Shinkai,et al. Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor* , 1998, The Journal of Biological Chemistry.
[36] W. Teague,et al. Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. , 1998, American journal of respiratory and critical care medicine.
[37] Janet Rossant,et al. A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.
[38] K. Alitalo,et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells , 1993, The Journal of experimental medicine.
[39] D. Dimitrov,et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.